Cognision and SOMNOmedics partner to provide sleep-biomarker tools in trials

Cognision has entered a strategic partnership with SOMNOmedics AG to advance the use of sleep biomarkers in pharmaceutical clinical trials. According to the company, Cognision will supply SOMNOmedics’ next-generation polysomnography (PSG) systems, tailored for use in regulated research environments. The deal combines Cognision’s experience in delivering neurophysiological biomarkers (such as EEG and event-related potentials) in […] The post Cognision and SOMNOmedics partner to provide sleep-biomarker tools in trials appeared first on Longevity.Technology.